After decades of effort, scientists have made real progress in understanding multiple sclerosis. While researchers long knew it was an autoimmune disorder that damages the myelin sheath that serves to ...

Synaptic injury in the IPL of the retina is linked to MS progression, with IPL thickness as a potential biomarker. Hypoxia in MS patients exacerbates inflammation and mitochondrial damage, ...

Researchers have developed a new and unique blood test to measure the immune response to the Epstein Barr Virus (EBV) which is the leading risk factor for developing multiple sclerosis (MS). Their ...

Multiple sclerosis (MS) is recognized as one of the most prevalent neurological diseases among young adults, with symptoms typically emerging between ages 20 to 40 years. The condition is ...

University of Virginia School of Medicine scientists have discovered a key determinant of our risk for multiple sclerosis (MS), advancing efforts to prevent and better treat the disease. Researchers ...

A multiple sclerosis diagnosis can feel overwhelming, especially when you start researching what it means for your future. Here’s what you need to know upfront — while multiple sclerosis may impact ...

Disability progression independent of relapse activity (PIRA) -- sometimes referred to as silent progression -- is a key integrating concept in the contemporary view of multiple sclerosis (MS). "The ...

The test that was developed using an existing diagnostic procedure as its basis and has the potential to be applied in clinical trials that target the Epstein Barr Virus. MS is a chronic neurological ...